E3 Life – Lifescience Investments

  • E3 Life invests directly into lifescience technologies and companies with the aim of fundamentally improving healthcare outcomes
  • We are passionate about innovation in lifescience and addressing unmet medical needs – we believe in funding technologies that can truly make a difference
  • Focus areas are biomanufacturing, haematology, cancer immunotherapy, infectious diseases, regenerative therapies and digital diagnostics

E3 Life – Transactional Advisory

  • E3 Life is a strategic partner in M&A processes, for buy-side and sell-side mandates
  • We provide investment and licensing partner identification and validation, technical and clinical assessment, patient flow and market modelling, valuation and synergy analysis as well as deal structuring, commercial terms negotiation and due diligence.

Unparalleled track record

  • The E3 Life executive team of seasoned life science professionals and advisory network has unique experience across the healthcare value chain
  • Exceptional track record of value creation and realisation by transforming healthcare companies organically and inorganically
  • Transactional experience encompasses all deal types and sizes, with total value exceeding $20 Billion

©2020 E3 Life AG

E3 Life AG, Grafenaustr. 5, 6302 Zug, Switzerland